wearing off 145
Safinamid: Dualer Wirkungsmechanismus als neue Therapieoption bei Morbus Parkinson - 05 - 2015 - Heftarchiv - PPT
Herken responsfluctuaties - Parkinson Smartwatch
Schematic representation of dyskinesias occurring in relation with a... | Download Scientific Diagram
Prevalence and risk factor of peak-dose dyskinesia in Thai patients with Parkinson's disease - MDS Abstracts
Relationship between LID and DOPA plasma level. “Peak of dose” or “on”... | Download Scientific Diagram
Levodopa-induzierte Dyskinesien bei Morbus Parkinson | SpringerLink
Parkinson disease
Therapie des idiopathischen Parkinson-Syndroms
Mean dyskinesia scores T SD in patients in the levodopa and lisuride... | Download Scientific Diagram
The Need for Enhanced Strategies to Manage Levodopa-Induced Dyskinesia in Parkinson's Disease
Ataxic Disorders | Basicmedical Key
Die Rolle von striatalen Tyrosinhydroxylase-positiven Neuronen bei L-DOPA-induzierten Dyskinesien der Maus
Cells | Special Issue : Dyskinesia in Parkinson's Disease: New Mechanisms and Molecular Targets
Pharmakotherapie beim Parkinson-Syndrom
Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson's Disease: A Neurocognitive Approach | IntechOpen
Medikamentöse Therapie der Parkinson-Krankheit: Eine interdisziplinäre Aufgabe
Mean dyskinesia scores T SD in patients in the levodopa and lisuride... | Download Scientific Diagram
